Anna Vähärautio

Anna Vähärautio

Helsingin yliopisto

H-index: 17

Europe-Finland

About Anna Vähärautio

Anna Vähärautio, With an exceptional h-index of 17 and a recent h-index of 14 (since 2020), a distinguished researcher at Helsingin yliopisto, specializes in the field of single-cell transcriptomics, cancer, ovarian cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract PR-007: Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous …

Patient-derived functional immuno-oncology platform identifies responders to ATR inhibitor and immunotherapy combinations in ovarian cancer

Abstract B077: Spatial patterns of immune cell states are associated with poor response to neoadjuvant chemotherapy in high-grade serous ovarian cancer

Studying the impact of CNVs on expression at single-cell resolution in HGSOC using autoencoders

Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level

Application of high-grade serous ovarian cancer organoids in functional precision medicine

Abstract A080: CD8+ T-cell interplay with myeloid cells as spatial determinant of chemotherapy response in the tumor microenvironment of metastatic high-grade serous ovarian cancer

Tracing back primed resistance in cancer via sister cells

Anna Vähärautio Information

University

Position

Academy Research Fellow PI

Citations(all)

2956

Citations(since 2020)

1526

Cited By

2041

hIndex(all)

17

hIndex(since 2020)

14

i10Index(all)

20

i10Index(since 2020)

17

Email

University Profile Page

Helsingin yliopisto

Google Scholar

View Google Scholar Profile

Anna Vähärautio Skills & Research Interests

single-cell transcriptomics

cancer

ovarian cancer

Top articles of Anna Vähärautio

Title

Journal

Author(s)

Publication Date

Abstract PR-007: Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous …

Cancer Research

Anniina Färkkilä

Ashwini S Nagaraj

Elina A Pietilä

Matilda Salko

Erdogan P Erkan

...

2024/3/4

Patient-derived functional immuno-oncology platform identifies responders to ATR inhibitor and immunotherapy combinations in ovarian cancer

bioRxiv

Ashwini S Nagaraj

Matilda Salko

Aditi Sirsikar

Erdogan Pekcan Erkan

Elina A Pietilä

...

2024

Abstract B077: Spatial patterns of immune cell states are associated with poor response to neoadjuvant chemotherapy in high-grade serous ovarian cancer

Cancer Research

Iga Niemiec

Essi Kahelin

Zhihan Liang

Erdogan P Erkan

Anna Vähärautio

...

2024/3/4

Studying the impact of CNVs on expression at single-cell resolution in HGSOC using autoencoders

Cancer Research

Matias Marin Falco

Teemu Närhi

Erdogan Pekcan Erkan

Johanna Hynninen

Anna Vähärautio

2024/3/22

Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level

Scientific Reports

Anna Perkiö

Barun Pradhan

Fatih Genc

Anna Pirttikoski

Sanna Pikkusaari

...

2024/2/21

Application of high-grade serous ovarian cancer organoids in functional precision medicine

Cancer Research

Wojciech Senkowski

Laura Gall-Mas

Matias M Falco

Yilin Li

Kari Lavikka

...

2024/3/22

Abstract A080: CD8+ T-cell interplay with myeloid cells as spatial determinant of chemotherapy response in the tumor microenvironment of metastatic high-grade serous ovarian cancer

Cancer Research

Inga-Maria P Launonen

Erdogan P Erkan

Iga Niemiec

Ada Junquera Mencía

Angela Szabo

...

2024/3/4

Tracing back primed resistance in cancer via sister cells

Nature Communications

Jun Dai

Shuyu Zheng

Matías M Falco

Jie Bao

Johanna Eriksson

...

2024/2/7

Abstract A027: Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma

Cancer Research

Sampsa Hautaniemi

Sanaz Jamalzadeh

Jun Dai

Kari Lavikka

Yilin Li

...

2024/3/4

Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma

BMC cancer

Sanaz Jamalzadeh

Jun Dai

Kari Lavikka

Yilin Li

Jing Jiang

...

2024/2/5

A platform utilizing high-grade serous ovarian cancer organoids for prospective patient stratification in functional precision medicine

Cancer Research

Wojciech Senkowski

Laura Gall-Mas

Matias M Falco

Yilin Li

Kari Lavikka

...

2023/4/4

Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function

Research Square

Sung-Min Hwang

Deepika Awasthi

Jieun Jeong

Tito Sandoval

Chang-Suk Chae

...

2023/12/14

Single-cell spatial dynamics of the tumor-immune microenvironment of high-grade serous ovarian cancer during neoadjuvant chemotherapy

Cancer Research

Inga-Maria Pauliina Launonen

Angela Szabo

Fernando Perez

Julia Casado

Zoltan Maliga

...

2023/4/4

Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer

TA Sandoval

C Chae

C Salvagno

D Awasthi

E Teran-Cabanillas

...

2023/10/25

The emerging role of the single-cell and spatial tumor microenvironment in high-grade serous ovarian cancer

Inga-Maria Launonen

Anna Vähärautio

Anniina Färkkilä

2023/10/1

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids

Developmental Cell

Wojciech Senkowski

Laura Gall-Mas

Matías Marín Falco

Yilin Li

Kari Lavikka

...

2023/6/19

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer

Science advances

Kaiyang Zhang

Erdogan Pekcan Erkan

Sanaz Jamalzadeh

Jun Dai

Noora Andersson

...

2022/2/23

Efficient establishment and utilization of a high-grade serous ovarian cancer organoid biobank

Cancer Research

Wojciech Senkowski

Laura Gall Mas

Matias M Falco

Yilin Li

Kari Lavikka

...

2022/6/15

Upregulation of ribosome biogenesis via canonical E-boxes is required for Myc-driven proliferation

Developmental Cell

Norman Zielke

Anna Vähärautio

Jianping Liu

Teemu Kivioja

Jussi Taipale

2022/4/25

A platform for efficient establishment, expansion and drug response profiling of high-grade serous ovarian cancer organoids

bioRxiv

Wojciech Senkowski

Laura Gall-Mas

Matias Marin Falco

Yilin Li

Kari Lavikka

...

2022/4/21

See List of Professors in Anna Vähärautio University(Helsingin yliopisto)

Co-Authors

H-index: 75
Jussi Taipale

Jussi Taipale

University of Cambridge

H-index: 63
Sten Linnarsson

Sten Linnarsson

Karolinska Institutet

H-index: 31
Kimmo Palin

Kimmo Palin

Helsingin yliopisto

H-index: 25
Kaisa Huhtinen

Kaisa Huhtinen

Turun yliopisto

H-index: 23
Minna Taipale

Minna Taipale

University of Cambridge

H-index: 22
Martin Enge

Martin Enge

Karolinska Institutet

academic-engine